Gene & Cell Therapy FAQs | ASGCT - American Society of Gene & Cell Therapy | ASGCT - American Society of Gene & Cell Therapy
![Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access - The Lancet Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access - The Lancet](https://www.thelancet.com/cms/attachment/5789602b-8611-4d1f-a049-ef7f9f723757/gr1_lrg.jpg)
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access - The Lancet
![Comparison between germline and somatic gene editing/therapy in terms... | Download Scientific Diagram Comparison between germline and somatic gene editing/therapy in terms... | Download Scientific Diagram](https://www.researchgate.net/publication/357825083/figure/fig1/AS:1181914622898178@1658801813778/Comparison-between-germline-and-somatic-gene-editing-therapy-in-terms-of-the-types-of.png)